fda compounding semaglutide warning letters october 2025 Letter Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Pharmacy Operating Without Control Drugmakers battle pharmacies over compounded

Because many of the major online exporters are based in this province, this effectively shut down the most common route Americans used to get GLP-1s from Canada

42,43 Of note, Abbass et al did not control for hemoglobin A1c, lipid levels, or history of cataract surgery, which could introduce bias

Starting cagrilintide when already on retatrutide If you are already established on retatrutide at a stable dose (meaning you have been at your current retatrutide dose for at least four weeks without significant GI issues), you can introduce cagrilintide at its lowest starting dose of 0.25 mg weekly

However, GLP-1 medications have longer lasting effects so these strategies will not have quite the same intensity or duration

Realistic timeline from assessment to first dose: 5-10 business days